| NCT02770599 |
Improving the Health Care in Inflammatory Bowel Disease. |
https://ClinicalTrials.gov/show/NCT02770599 |
Active, not recruiting |
University Hospital of North Norway |
2020-03-20 |
| NCT00001184 |
Immune Regulation in Ulcerative Colitis or Crohn s Disease |
https://ClinicalTrials.gov/show/NCT00001184 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03397108 |
Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03397108 |
Recruiting |
The Hospital for Sick Children |
2020-07-31 |
| NCT03801928 |
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03801928 |
Completed |
Pfizer |
2020-02-07 |
| NCT03366090 |
Immunological Profiles in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03366090 |
Recruiting |
Rijnstate Hospital |
2020-07-01 |
| NCT03824561 |
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] |
https://ClinicalTrials.gov/show/NCT03824561 |
Recruiting |
Takeda |
2022-01-31 |
| NCT03282903 |
The PRognostic Effect of Environmental Factors in Crohn’s and Colitis |
https://ClinicalTrials.gov/show/NCT03282903 |
Recruiting |
University of Edinburgh |
2020-10-31 |
| NCT03223012 |
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service |
https://ClinicalTrials.gov/show/NCT03223012 |
Completed |
AbbVie |
2019-02-28 |
| NCT03179865 |
Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03179865 |
Completed |
Wolfson Medical Center |
2020-02-29 |
| NCT03143517 |
Fecal Calprotectin Collection Protocol |
https://ClinicalTrials.gov/show/NCT03143517 |
Completed |
DiaSorin Inc. |
2018-08-23 |
| NCT03142113 |
Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03142113 |
Completed |
Universitaire Ziekenhuizen Leuven |
2016-12-31 |
| NCT03090139 |
Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets |
https://ClinicalTrials.gov/show/NCT03090139 |
Completed |
Takeda |
2018-06-13 |
| NCT03079700 |
Immune Modulation From Trichuris Suis |
https://ClinicalTrials.gov/show/NCT03079700 |
Completed |
University of Aarhus |
2012-12-31 |
| NCT03006198 |
Tracking Biologics Along the Silk Road |
https://ClinicalTrials.gov/show/NCT03006198 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
2018-12-01 |
| NCT02986724 |
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) |
https://ClinicalTrials.gov/show/NCT02986724 |
Active, not recruiting |
Takeda |
2020-08-31 |
| NCT02925338 |
National Observational Study On The Use Of Inflectraâ„¢ An Infliximab Biosimilar In Real Life |
https://ClinicalTrials.gov/show/NCT02925338 |
Recruiting |
Pfizer |
2020-09-23 |
| NCT02925260 |
MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography |
https://ClinicalTrials.gov/show/NCT02925260 |
Completed |
London North West Healthcare NHS Trust |
2019-04-01 |
| NCT02868398 |
Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab |
https://ClinicalTrials.gov/show/NCT02868398 |
Completed |
Evangelismos Hospital |
2020-04-30 |
| NCT02846961 |
Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02846961 |
Recruiting |
Kyungpook National University Hospital |
2018-09-30 |
| NCT02808780 |
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02808780 |
Recruiting |
Janssen Biotech, Inc. |
2031-07-30 |
| NCT02799615 |
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children |
https://ClinicalTrials.gov/show/NCT02799615 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-02-11 |
| NCT02778464 |
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02778464 |
Completed |
The Royal Wolverhampton Hospitals NHS Trust |
2020-01-31 |
| NCT02750800 |
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) |
https://ClinicalTrials.gov/show/NCT02750800 |
Completed |
AbbVie |
2018-04-03 |
| NCT02745457 |
Body Composition in Children With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02745457 |
Active, not recruiting |
Schneider Children’s Medical Center, Israel |
2020-05-30 |
| NCT02735941 |
Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases |
https://ClinicalTrials.gov/show/NCT02735941 |
Completed |
Medical University of Graz |
2018-07-27 |
| NCT02727959 |
Inflammatory Bowel Disease in South Eastern Norway |
https://ClinicalTrials.gov/show/NCT02727959 |
Completed |
Oslo University Hospital |
2019-12-31 |
| NCT02717897 |
Vitamin D and Disease Activity in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02717897 |
Completed |
University of Chicago |
2013-05-31 |
| NCT02693730 |
Phenotyping IBS: Perceptions and Modulations of Visceral Sensations |
https://ClinicalTrials.gov/show/NCT02693730 |
Active, not recruiting |
University of California, Los Angeles |
2020-08-31 |
| NCT02674308 |
Entyvio (Vedolizumab) Long Term Safety Study |
https://ClinicalTrials.gov/show/NCT02674308 |
Active, not recruiting |
Takeda |
2021-07-22 |
| NCT02640391 |
Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02640391 |
Completed |
Kyungpook National University Hospital |
2018-12-31 |
| NCT02586259 |
Effectiveness of Cortiment® in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02586259 |
Completed |
Ferring Pharmaceuticals |
2018-04-05 |
| NCT02678052 |
OTIS Vedolizumab Pregnancy Exposure Registry |
https://ClinicalTrials.gov/show/NCT02678052 |
Recruiting |
Takeda |
2022-11-30 |
| NCT03404557 |
Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC |
https://ClinicalTrials.gov/show/NCT03404557 |
Completed |
University Hospital, Clermont-Ferrand |
2019-01-18 |
| NCT02738125 |
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions |
https://ClinicalTrials.gov/show/NCT02738125 |
Active, not recruiting |
AbbVie |
2028-11-20 |
| NCT02542917 |
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study |
https://ClinicalTrials.gov/show/NCT02542917 |
Completed |
King’s College Hospital NHS Trust |
2016-07-31 |
| NCT02539368 |
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02539368 |
Completed |
Pfizer |
2018-10-31 |
| NCT02506179 |
Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02506179 |
Completed |
AbbVie |
2020-02-10 |
| NCT02502552 |
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort |
https://ClinicalTrials.gov/show/NCT02502552 |
Completed |
Centre Hospitalier Universitaire de Saint Etienne |
2015-10-31 |
| NCT02499263 |
A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT02499263 |
Completed |
AbbVie |
2018-09-17 |
| NCT02439372 |
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02439372 |
Completed |
Asan Medical Center |
2016-06-30 |
| NCT02438410 |
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02438410 |
Completed |
Mayo Clinic |
2019-12-04 |
| NCT02399683 |
Immune Modulation From Trichuris Trichiura |
https://ClinicalTrials.gov/show/NCT02399683 |
Completed |
University of Aarhus |
2012-12-31 |
| NCT02368743 |
QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) |
https://ClinicalTrials.gov/show/NCT02368743 |
Completed |
Ferring Pharmaceuticals |
2017-03-31 |
| NCT02322008 |
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice |
https://ClinicalTrials.gov/show/NCT02322008 |
Completed |
Regionshospitalet Viborg, Skive |
2011-03-31 |
| NCT02316678 |
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics |
https://ClinicalTrials.gov/show/NCT02316678 |
Completed |
University of Pennsylvania |
2016-12-31 |
| NCT02274714 |
Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02274714 |
Completed |
University of Wisconsin, Madison |
2017-01-31 |
| NCT02229344 |
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea |
https://ClinicalTrials.gov/show/NCT02229344 |
Active, not recruiting |
Janssen Korea, Ltd., Korea |
2022-02-22 |
| NCT02161640 |
Vascular Dysfunction in Paediatric IBD |
https://ClinicalTrials.gov/show/NCT02161640 |
Completed |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2016-11-30 |
| NCT02149043 |
Thermography in Surveillance of Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02149043 |
Completed |
University Hospital Dubrava |
2018-01-31 |
| NCT02135289 |
The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID |
https://ClinicalTrials.gov/show/NCT02135289 |
Completed |
Chinese University of Hong Kong |
2019-07-31 |
| NCT02110862 |
Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02110862 |
Completed |
Odense University Hospital |
2013-08-31 |
| NCT01301976 |
Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01301976 |
Completed |
UPECLIN HC FM Botucatu Unesp |
2010-03-31 |
| NCT01289366 |
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT01289366 |
Completed |
University of Erlangen-Nürnberg Medical School |
2011-08-31 |
| NCT01282905 |
Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01282905 |
Completed |
KU Leuven |
NA |
| NCT02057016 |
Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02057016 |
Completed |
Catholic University of the Sacred Heart |
2014-12-31 |
| NCT02054533 |
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT02054533 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-06-30 |
| NCT01966744 |
Self-Management Assistance for Recommended Treatment (SMART) Portal |
https://ClinicalTrials.gov/show/NCT01966744 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2016-06-30 |
| NCT01960439 |
Responsiveness of Endoscopic Evaluation in UC |
https://ClinicalTrials.gov/show/NCT01960439 |
Completed |
University of Western Ontario, Canada |
2015-07-31 |
| NCT01947816 |
Special Investigation in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01947816 |
Completed |
AbbVie |
2018-02-15 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01916161 |
The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients |
https://ClinicalTrials.gov/show/NCT01916161 |
Completed |
National Health Service, United Kingdom |
2016-02-29 |
| NCT01891214 |
Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01891214 |
Completed |
Rennes University Hospital |
2016-04-30 |
| NCT01861288 |
Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01861288 |
Completed |
Herlev Hospital |
2016-09-05 |
| NCT01852760 |
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound |
https://ClinicalTrials.gov/show/NCT01852760 |
Completed |
Lawson Health Research Institute |
2015-07-31 |
| NCT01848561 |
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) |
https://ClinicalTrials.gov/show/NCT01848561 |
Recruiting |
AbbVie |
2027-04-06 |
| NCT01813500 |
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients |
https://ClinicalTrials.gov/show/NCT01813500 |
Completed |
Boston Medical Center |
2015-09-30 |
| NCT01798953 |
Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis |
https://ClinicalTrials.gov/show/NCT01798953 |
Completed |
Sahlgrenska University Hospital, Sweden |
2013-02-28 |
| NCT01768858 |
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT01768858 |
Completed |
AbbVie |
2017-08-13 |
| NCT01740349 |
Evaluation Of The Pillcamâ„¢ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01740349 |
Completed |
Azienda Policlinico Umberto I |
2012-09-30 |
| NCT01705522 |
Multimodal Approach in IBD Patients |
https://ClinicalTrials.gov/show/NCT01705522 |
Recruiting |
Clinical Hospital Colentina |
2019-09-30 |
| NCT01678300 |
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) |
https://ClinicalTrials.gov/show/NCT01678300 |
Completed |
Beth Israel Deaconess Medical Center |
2015-11-30 |
| NCT01676324 |
FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT01676324 |
Completed |
University of British Columbia |
2013-03-31 |
| NCT01654783 |
Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA |
https://ClinicalTrials.gov/show/NCT01654783 |
Completed |
Kyorin Pharmaceutical Co.,Ltd |
2014-06-30 |
| NCT01604564 |
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients |
https://ClinicalTrials.gov/show/NCT01604564 |
Active, not recruiting |
Universitaire Ziekenhuizen Leuven |
2019-12-31 |
| NCT01517607 |
Mesalazine (PENTASA®) in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01517607 |
Completed |
Ferring Pharmaceuticals |
2013-12-31 |
| NCT01517594 |
Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01517594 |
Completed |
Ferring Pharmaceuticals |
2013-06-30 |
| NCT01517516 |
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. |
https://ClinicalTrials.gov/show/NCT01517516 |
Completed |
University of California, Los Angeles |
2015-07-31 |
| NCT01468090 |
Disease Course in an IBD Cohort in the Era of Biological Treatment |
https://ClinicalTrials.gov/show/NCT01468090 |
Completed |
Hvidovre University Hospital |
2014-06-30 |
| NCT01467609 |
PillCam Colon Capsule Endoscopy for Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01467609 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2010-07-31 |
| NCT01405105 |
Exacerbating Factors in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01405105 |
Completed |
Dallas VA Medical Center |
2012-06-30 |
| NCT01387698 |
Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01387698 |
Completed |
Ferring Pharmaceuticals |
2015-10-31 |
| NCT01364896 |
Anal Human Papillomavirus in Inflammatory Bowel Disease Study |
https://ClinicalTrials.gov/show/NCT01364896 |
Completed |
University of Pittsburgh |
2014-01-31 |
| NCT01363453 |
User Surveillance in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01363453 |
Completed |
Ferring Pharmaceuticals |
2008-05-31 |
| NCT01349504 |
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01349504 |
Completed |
Beth Israel Deaconess Medical Center |
2012-12-31 |
| NCT01331551 |
Mesalamine and Reproductive Health Study |
https://ClinicalTrials.gov/show/NCT01331551 |
Completed |
Harvard School of Public Health |
2018-08-31 |
| NCT04272307 |
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. |
https://ClinicalTrials.gov/show/NCT04272307 |
Recruiting |
University Hospital, Bordeaux |
2021-02-28 |
| NCT04197973 |
Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients |
https://ClinicalTrials.gov/show/NCT04197973 |
Recruiting |
Keimyung University Dongsan Medical Center |
2020-06-20 |
| NCT04191707 |
Metabolomic Markers of Fatigue in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT04191707 |
Completed |
Corporacion Parc Tauli |
2019-12-01 |
| NCT04191395 |
Evolution and Treatments of Chronic Inflammatory Systemic Diseases |
https://ClinicalTrials.gov/show/NCT04191395 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2029-12-31 |
| NCT04151420 |
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment |
https://ClinicalTrials.gov/show/NCT04151420 |
Recruiting |
Maastricht University Medical Center |
2021-11-30 |
| NCT04148274 |
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT04148274 |
Recruiting |
ProgenaBiome |
2023-03-31 |
| NCT04131530 |
Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence |
https://ClinicalTrials.gov/show/NCT04131530 |
Recruiting |
Shandong University |
2019-12-31 |
| NCT04089514 |
A Real-world Study of Imraldi® Use |
https://ClinicalTrials.gov/show/NCT04089514 |
Recruiting |
Biogen |
2021-06-30 |
| NCT04079335 |
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD |
https://ClinicalTrials.gov/show/NCT04079335 |
Recruiting |
Chinese University of Hong Kong |
2021-01-28 |
| NCT03262649 |
Manitoba Inflammatory Bowel Disease Cohort Study |
https://ClinicalTrials.gov/show/NCT03262649 |
Completed |
University of Manitoba |
2016-03-01 |
| NCT03952364 |
The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States |
https://ClinicalTrials.gov/show/NCT03952364 |
Recruiting |
PredictImmune Ltd |
2021-06-30 |
| NCT03952195 |
Complications and Outcomes of Pouch Excision |
https://ClinicalTrials.gov/show/NCT03952195 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-04-01 |
| NCT03947931 |
Russian Extremely Severe Ulcerative Colitis Study |
https://ClinicalTrials.gov/show/NCT03947931 |
Recruiting |
State Scientific Centre of Coloproctology, Russian Federation |
2021-06-20 |
| NCT03942861 |
Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. |
https://ClinicalTrials.gov/show/NCT03942861 |
Recruiting |
Copenhagen University Hospital at Herlev |
2020-08-21 |
| NCT03907631 |
Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) |
https://ClinicalTrials.gov/show/NCT03907631 |
Recruiting |
Hull University Teaching Hospitals NHS Trust |
2020-09-01 |
| NCT03884439 |
Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) |
https://ClinicalTrials.gov/show/NCT03884439 |
Recruiting |
Pfizer |
2023-03-13 |
| NCT03841045 |
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03841045 |
Recruiting |
Soroka University Medical Center |
2020-12-31 |
| NCT03839680 |
Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03839680 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2019-04-15 |
| NCT03836612 |
Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03836612 |
Completed |
Momentum Data |
2019-09-01 |
| NCT03808506 |
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03808506 |
Recruiting |
Lawson Health Research Institute |
2021-06-30 |
| NCT03802214 |
Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF（Tumor Necrosis Factor）Therapy |
https://ClinicalTrials.gov/show/NCT03802214 |
Recruiting |
Stanford University |
2021-12-31 |
| NCT03788824 |
Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE |
https://ClinicalTrials.gov/show/NCT03788824 |
Recruiting |
Shandong University |
2018-12-31 |
| NCT03773445 |
Golimumab Trough Levels in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03773445 |
Recruiting |
Hospital San Carlos, Madrid |
2019-10-31 |
| NCT03765450 |
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03765450 |
Recruiting |
Robarts Clinical Trials Inc. |
2019-12-31 |
| NCT03747068 |
The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. |
https://ClinicalTrials.gov/show/NCT03747068 |
Completed |
HaEmek Medical Center, Israel |
2015-10-09 |
| NCT03710486 |
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants |
https://ClinicalTrials.gov/show/NCT03710486 |
Recruiting |
Takeda |
2021-09-30 |
| NCT03698812 |
A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT03698812 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2020-09-30 |
| NCT03689673 |
Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) |
https://ClinicalTrials.gov/show/NCT03689673 |
Active, not recruiting |
Ipsen |
2020-12-31 |
| NCT03669822 |
Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) |
https://ClinicalTrials.gov/show/NCT03669822 |
Recruiting |
Johns Hopkins University |
2020-12-31 |
| NCT03662919 |
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study |
https://ClinicalTrials.gov/show/NCT03662919 |
Recruiting |
Biogen |
2022-06-30 |
| NCT03643211 |
Xeljanz Special Investigation for Long-term Use in UC Patients |
https://ClinicalTrials.gov/show/NCT03643211 |
Active, not recruiting |
Pfizer |
2022-01-05 |
| NCT03640637 |
The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03640637 |
Enrolling by invitation |
Odense University Hospital |
2020-12-31 |
| NCT03589183 |
Gut Microbiome in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03589183 |
Recruiting |
Kyunghee University Medical Center |
2028-03-31 |
| NCT03578692 |
Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC) |
https://ClinicalTrials.gov/show/NCT03578692 |
Completed |
Nanjing PLA General Hospital |
2018-01-31 |
| NCT03565432 |
Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases |
https://ClinicalTrials.gov/show/NCT03565432 |
Active, not recruiting |
Kyunghee University Medical Center |
2019-07-30 |
| NCT03553472 |
Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster |
https://ClinicalTrials.gov/show/NCT03553472 |
Completed |
University of Wisconsin, Madison |
2019-05-31 |
| NCT03549988 |
Pro-active Fecal Calprotectin Monitoring PROMOTE-UC |
https://ClinicalTrials.gov/show/NCT03549988 |
Recruiting |
University of British Columbia |
2020-06-30 |
| NCT03532932 |
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice |
https://ClinicalTrials.gov/show/NCT03532932 |
Recruiting |
Takeda |
2021-07-15 |
| NCT03501758 |
Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound |
https://ClinicalTrials.gov/show/NCT03501758 |
Recruiting |
Haukeland University Hospital |
2023-12-30 |
| NCT03488030 |
A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) |
https://ClinicalTrials.gov/show/NCT03488030 |
Completed |
Takeda |
2019-05-31 |
| NCT03477032 |
FMT in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT03477032 |
Recruiting |
St Vincent’s Hospital Melbourne |
2019-12-31 |
| NCT03460847 |
Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa |
https://ClinicalTrials.gov/show/NCT03460847 |
Recruiting |
Medical University of Graz |
2020-03-31 |
| NCT03452501 |
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients |
https://ClinicalTrials.gov/show/NCT03452501 |
Active, not recruiting |
Hikma Pharmaceuticals LLC |
2020-06-30 |
| NCT01169207 |
Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study |
https://ClinicalTrials.gov/show/NCT01169207 |
Active, not recruiting |
Johns Hopkins University |
2020-12-31 |
| NCT01140789 |
GWA Study in Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT01140789 |
Recruiting |
Chinese University of Hong Kong |
2037-04-30 |
| NCT01104753 |
A Study of Pentasa in Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT01104753 |
Completed |
Ferring Pharmaceuticals |
2010-10-31 |
| NCT01099111 |
Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders |
https://ClinicalTrials.gov/show/NCT01099111 |
Completed |
King Fahad Medical City |
2012-01-31 |
| NCT01095432 |
Partial Wave Spectroscopic Detection of Colon Cancer Risk |
https://ClinicalTrials.gov/show/NCT01095432 |
Completed |
University of Chicago |
2015-11-30 |
| NCT01091558 |
Study of Effects of L-Arginine in Colitis and Colon Cancer |
https://ClinicalTrials.gov/show/NCT01091558 |
Completed |
Vanderbilt University Medical Center |
2011-12-31 |
| NCT01032525 |
Monroe County Inflammatory Bowel Disease (IBD) Registry |
https://ClinicalTrials.gov/show/NCT01032525 |
Completed |
University of Rochester |
2013-05-31 |
| NCT00961948 |
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT00961948 |
Completed |
Mayo Clinic |
2013-02-28 |
| NCT00917514 |
An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen |
https://ClinicalTrials.gov/show/NCT00917514 |
Completed |
Medicpen AB |
2010-02-28 |
| NCT02423512 |
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness |
https://ClinicalTrials.gov/show/NCT02423512 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-06-13 |
| NCT02261636 |
Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment |
https://ClinicalTrials.gov/show/NCT02261636 |
Completed |
Ferring Pharmaceuticals |
2019-01-14 |
| NCT01301417 |
Data Collection of Patients Treated With the ColonRingâ„¢ for the Creation of Circular Compression Anastomosis |
https://ClinicalTrials.gov/show/NCT01301417 |
Completed |
novoGI |
2011-08-31 |
| NCT04411784 |
PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT04411784 |
Active, not recruiting |
Hull University Teaching Hospitals NHS Trust |
2020-07-31 |
| NCT03663400 |
Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples |
https://ClinicalTrials.gov/show/NCT03663400 |
Recruiting |
NYU Langone Health |
2020-09-30 |
| NCT03535649 |
A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants |
https://ClinicalTrials.gov/show/NCT03535649 |
Completed |
Takeda |
2018-12-18 |
| NCT00780507 |
Fecal Biomarker Study for Patients With Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT00780507 |
Completed |
Warner Chilcott |
2009-07-31 |
| NCT00705484 |
European Safety Registry in Ulcerative Colitis (P04808) |
https://ClinicalTrials.gov/show/NCT00705484 |
Completed |
Merck Sharp & Dohme Corp. |
2016-10-20 |
| NCT00606346 |
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00606346 |
Active, not recruiting |
Janssen Biotech, Inc. |
2037-11-15 |
| NCT00604422 |
Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT00604422 |
Completed |
Medtronic - MITG |
2010-02-28 |
| NCT00587236 |
Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis |
https://ClinicalTrials.gov/show/NCT00587236 |
Completed |
Mayo Clinic |
2010-08-31 |
| NCT00516776 |
The Innate Immune System and Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00516776 |
Completed |
Norwegian University of Science and Technology |
2017-12-31 |
| NCT00474097 |
Follow-Up Phone Calls After Colorectal Surgery |
https://ClinicalTrials.gov/show/NCT00474097 |
Completed |
University Hospitals Cleveland Medical Center |
2007-12-31 |
| NCT00468455 |
Post-Op Quality of Life After Colorectal Surgery |
https://ClinicalTrials.gov/show/NCT00468455 |
Completed |
University Hospitals Cleveland Medical Center |
2008-04-30 |
| NCT00463619 |
Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT00463619 |
Completed |
Heidelberg University |
2010-04-30 |
| NCT00403923 |
Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT00403923 |
Completed |
University Hospitals, Leicester |
2007-06-30 |
| NCT00274209 |
Chromoendoscopy for Ulcerative Colitis Surveillance |
https://ClinicalTrials.gov/show/NCT00274209 |
Completed |
Indiana University |
2011-11-30 |
| NCT00222378 |
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00222378 |
Completed |
University of Miami |
2012-06-30 |
| NCT00215020 |
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00215020 |
Completed |
Boston Children’s Hospital |
2006-06-30 |
| NCT00207688 |
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients |
https://ClinicalTrials.gov/show/NCT00207688 |
Completed |
Janssen Research & Development, LLC |
2015-09-09 |
| NCT00061737 |
Quality of Life in Pediatric Inflammatory Bowel Disease |
https://ClinicalTrials.gov/show/NCT00061737 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |